Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population

Croatian Medical Journal

Volumn 49, Issue 2, 2008, Pages 182-191

  Židzik, Jozef ^a   Slabá, Eva ^a   Joppa, Pavol ^b   Kluchová, Zuzana ^b   Dorková, Zuzana ^b   Skyba, Peter ^b   Habalová, Viera ^a   Šalagovič, Ján ^a   Tkáčová, Ružena ^b  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

EPOXIDE HYDROLASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SLOVAKIA;

CASE-CONTROL STUDIES; EPOXIDE HYDROLASES; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SLOVAKIA;

EID: 43449100687     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2008.2.182     Document Type: Article

References (38)

1. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-46.
2. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532-55.
3. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61:935-9.
4. Sandford AJ, Silverman EK. Chronic obstructive pulmonary disease. Susceptibility factors for COPD the genotypeenvironment interaction. Thorax. 2002;57:736-41.
5. Janoff A. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis. 1985;132:417-33.
6. Janus ED, Phillips NT, Carrell RW. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet. 1985;1:152-4.
7. Molfino NA. Genetics of COPD. Chest. 2004;125:1929-40.
8. He JQ, Ruan J, Connett JE, Anthonisen NR, Pare PD, Sandford AJ. Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med. 2002;166:323-8.
9. Smith CA, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet. 1997;350:630-3.
10. Harrison DJ, Hubbard AL, MacMillan J, Wyllie AH, Smith CA. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer. 1999;79:168-71.
11. Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet. 1994;3:421-8.
12. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Pare PD. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med. 2001;163:469-73.
13. Park JY, Chen L, Wadhwa N, Tockman MS. Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. Int J Mol Med. 2005;15:443-8.
14. Cheng SL, Yu CJ, Chen CJ, Yang PC. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J. 2004;23:818-24.
15. Rodriguez F, Jardi R, Costa X, Juan D, Galimany R, Vidal R, et al. Detection of polymorphisms at exons 3 (Tyr113→His) and 4 (His139→Arg) of the microsomal epoxide hydrolase gene using fluorescence PCR method combined with melting curves analysis. Anal Biochem. 2002;308:120-6.
16. Takeyabu K, Yamaguchi E, Suzuki I, Nishimura M, Hizawa N, Kamakami Y. Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population. Eur Respir J. 2000;15:891-4.
17. Yim JJ, Park GY, Lee CT, Kim YW, Han SK, Shim YS, et al. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax. 2000;55:121-5.
18. Matheson MC, Raven J, Walters EH, Abramson MJ, Ellis JA. Microsomal epoxide hydrolase is not associated with COPD in a community-based sample. Hum Biol. 2006;78:705-17.
19. Ketterer B, Harris JM, Talaska G, Meyer DJ, Pemble SE, Taylor JB, et al. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer. Environ Health Perspect. 1992;98:87-94.
20. Mannervik B, Danielson UH. Glutathione transferases - structure and catalytic activity. CRC Crit Rev Biochem. 1988;23:283-337.
21. Harrison DJ, Cantlay AM, Rae F, Lamb D, Smith CA. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol. 1997;16:356-60.
22. Tkacova R, Salagovic J, Ceripkova M, Tkac I, Stubna J, Kalina I. Glutathione S-transferase M1 gene polymorphism is related to COPD in patients with non-small-cell lung cancer. Wien Klin Wochenschr. 2004;116:131-4.
23. Schneider J, Bernges U, Philipp M, Woitowitz HJ. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett. 2004;208:65-74.
24. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-38.
25. Arand M, Muhlbauer R, Hengstler J, Jager E, Fuchs J, Winkler L, et al. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem. 1996;236:184-6.
26. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst. 1993;85:1159-64.
27. Gart JJ. Point and interval estimation of the common odds ratio in the combination of 2 x 2 tables with fixed marginals. Biometrika. 1970;57:471-5.
28. Givelber RJ, Couropmitree NN, Gottlieb DJ, Evans JC, Levy D, Myers RH, et al. Segregation analysis of pulmonary function among families in the Framingham Study. Am J Respir Crit Care Med. 1998;157:1445-51.
29. Wilk JB, DeStefano AL, Arnett DK, Rich SS, Djousse L, Crapo RO, et al. A genome-wide scan of pulmonary function measures in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Respir Crit Care Med. 2003;167:1528-33.
30. Lomas DA, Silverman EK. The genetics of chronic obstructive pulmonary disease. Respir Res. 2001;2:20-6.
31. Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, Pare PD, et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet. 2002;11:569-76.
32. Hersh CP, Demeo DL, Lazarus R, Celedon JC, Raby BA, Benditt JO, et al. Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173:977-84.
33. Silverman EK. Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc. 2006;3:405-8.
34. Habalova V, Salagovic J, Kalina I, Stubna J. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients. Neoplasma. 2004;51:352-7.
35. Hersh CP, Demeo DL, Lange C, Litonjua AA, Reilly JJ, Kwiatkowski D, et al. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Am J Respir Cell Mol Biol. 2005;33:71-8.
36. Brogger J, Steen VM, Eiken HG, Gulsvik A, Bakke P. Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1. Eur Respir J. 2006;27:682-8.
37. Baranova H, Perriot J, Albuisson E, Ivaschenko T, Baranov VS, Hemery B, et al. Peculiarities of the GSTM1 0/0 genotype in French heavy smokers with various types of chronic bronchitis. Hum Genet. 1997;99:822-6.
38. Keicho N, Emi M, Kajita M, Matsushita I, Nakata K, Azuma A, et al. Overestimated frequency of a possible emphysema-susceptibility allele when microsomal epoxide hydrolase is genotyped by the conventional polymerase chain reaction-based method. J Hum Genet. 2001;46:96-8.